Korea Set to Approve Stem-Cell Drugs for Cartilage Repair

  
 
Korea Set to Approve Stem-Cell Drugs for Cartilage Repair (Biloine Young @ OTW)
The officials of two South Korean biotechnology firms expect to receive Korean Food and Drug Administration (KFDA) approval for their stem cell drugs this month. Approval will pave the way for the world’s second stem cell-based medicines to enter the market.
The first drug is called “Cartistem”, produced by Medipost, Inc. for treatment of degenerative arthritis and knee cartilage defects. The second is a stem cell-based anal fistula drug made by Anterogen, Co. Officials of both companies expects their dru...